Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

Launched by KHYBER MEDICAL UNIVERSITY PESHAWAR · Aug 17, 2024

Keywords

ClinConnect Summary

The EMPOWER-D trial is a study focused on preventing and controlling Type II Diabetes Mellitus (TIIDM) and its early stage, known as intermediate hyperglycemia, in rural areas of Peshawar and Swabi, Pakistan. The goal of the trial is to involve community members in learning and taking action together to manage diabetes better. Researchers will adapt and test a program that has worked well in similar communities in Bangladesh, aiming to improve health through community participation and tailored interventions.

To participate in this trial, individuals must be at least 20 years old and live in the rural areas of Peshawar or Swabi. People with normal blood sugar levels, those with intermediate hyperglycemia, and individuals already diagnosed with diabetes are all welcome to join. Participants can expect to attend community meetings and activities designed to help them understand and manage diabetes effectively. This study offers a chance to be part of a meaningful effort to improve health in the community while also helping researchers gather valuable information that could benefit others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals aged 20 years and above.
• • Participants residing in the rural areas of Peshawar and Swabi, Pakistan.
• • Individuals willing to participate in the study and provide consent.
• • Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
• • Participants who can attend the scheduled meetings and interventions as per the study protocol.
• Exclusion Criteria:
• • Individuals below the age of 20 years.
• • Individuals unwilling to provide consent for participation.
• • Participants with severe health conditions that may hinder their active involvement in the study.
• • Individuals with a history of non-compliance with medical interventions or research protocols